Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats

被引:0
|
作者
Wang, X
Zhong, YX
Zhang, ZY
Lu, J
Lan, M
Miao, JY
Guo, XG
Shi, YQ
Zhao, YQ
Ding, J
Wu, KC
Pan, BR
Fan, DM [1 ]
机构
[1] Military Med Univ 4, Xijing Hosp, Inst Digest Dis, Shaanxi 710033, Peoples R China
[2] Military Med Univ 4, Tangdu Hosp, Emergency Dept, Shaanxi 710038, Peoples R China
[3] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Oncol Ctr, Xian 710032, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. METHODS: Rats with cirrhosis induced by carbon tetrachloride were randomly divided into two groups, one( n = 13) receiving 0. 5 mg . kg(-1) per day of N-G-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, for 10 days, whereas the other group ( n = 13) and control ( n = 10) rats were administrated the same volume of 9 g . L-1 saline. Half gastric emptying time and 2 h residual rate were measured by SPECT, using (99m) Tc-DTPA-labeled barium sulfate as test meal. Gastrointestinal transition time was recorded simultaneously. Serum concentration of nitric oxide ( NO) was determined by the kinetic cadmium reduction and colorimetric methods. Immunolhistochemical SABC method was used to observe the expression and distribution of three types of nitric oxide synthase (NOS) isoforms in the rat gastrointestinal tract. Western blot was used to detect expression of gastrointestinal NOS isoforms. RESULTS: Half gastric emptying time and transgastrointestinal time were significantly prolonged( 124. 0 +/- 26. 4 min; 33.7 +/- 8.9 min;72.1 +/- 15.3 min; P < 0.01), (12.4 +/- 0.5 h; 9.5 +/- 0.3 h; 8.2 +/- 0.8 h; P < 0. 01), 2 h residual rate was raised in cirrhotic rats than in controls and cirrhotic rats treated with L-NAME(54.9 +/- 7.6 %,13.7 +/- 3.2 %, 34.9 +/- 10.3 %, P < 0.01). Serum concentration of NO was significantly increased in cirrhotic rats than in the other groups (8.20 +/- 2.48) mumol . L-1, (5.94 +/- 1.07) mumol . L-1, and control (5.66 +/- 1.60) mumol . L-1, P < 0.01. NOS staining intensities which were mainly located in the gastrointestinal tissues were markedly lower in cirrhotic rats than in the controls and cirrhotic rats after treated with L-NAME. CONCLUSION: Gastrointestinal motility was remarkably inhibited in cirrhotic rats, which could be alleviated by L-NAME. Nitric oxide may play an important role in the inhibition of gastrointestinal motility in cirrhotic rats.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 50 条
  • [41] Failure of L-NAME to cause inhibition of nitric oxide synthesis: Role of inducible nitric oxide synthase
    Miller, MJS
    Thompson, JH
    Liu, X
    ElobyChildress, S
    SadowskaKrowicka, H
    Zhang, XJ
    Clark, DA
    INFLAMMATION RESEARCH, 1996, 45 (06) : 272 - 276
  • [42] Sympathetic contribution for the hemodynamic alterations induced by L-NAME in conscious and anesthetized rats
    Biancardi, VC
    Bergamaschi, CT
    Lopes, OU
    Campos, RR
    FASEB JOURNAL, 2003, 17 (05): : A1230 - A1230
  • [43] Nitric oxide synthase inhibitor (L-NAME) impair the diaphragm function in rat
    Sugiuchi, N
    Takagi, S
    Kikuchi, S
    Seki, I
    Aoki, T
    10TH ASEAN CONGRESS OF ANAESTHESIOLOGISTS / 2ND MEETING OF ASIAN SOCIETY OF CARDIOTHORACIC ANAESTHESIA, 1997, : 165 - 168
  • [44] Modification by L-NAME of codeine induced analgesia: Possible role of nitric oxide
    Khattab, MM
    El-Hadiyah, TM
    Al-Shabanah, OA
    Raza, M
    RECEPTORS & CHANNELS, 2004, 10 (5-6): : 139 - 145
  • [45] L-NAME Releases Nitric Oxide and Potentiates Subsequent Nitroglycerin Mediated Vasodilation
    Liu, Taiming
    Zhang, Meijuan
    Mukoseraa, George
    Borchardtb, Dan
    Li, Qian
    Tipple, Trent
    Ahmedd, Abu Shufian Ishtiaq
    Power, Gordon
    Blood, Arlin
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 145 : S114 - S115
  • [46] Vasoactive systems in L-NAME hypertension:: the role of inducible nitric oxide synthase
    Pechánová, O
    Dobesová, Z
    Cejka, J
    Kunes, J
    Zicha, J
    JOURNAL OF HYPERTENSION, 2004, 22 (01) : 167 - 173
  • [47] The vasoconstrictor effects of L-NAME, a nitric oxide synthase inhibitor, in pregnant rabbits
    Losonczy, G
    Mucha, I
    Muller, V
    Kriston, T
    Ungvari, Z
    Tornoci, L
    Rosivall, L
    Venuto, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (04) : 1012 - 1018
  • [48] Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat
    Hu, CT
    Chang, KC
    Wu, CY
    Chen, HI
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) : 1237 - 1243
  • [49] Cardiorespiratory impact of the nitric oxide synthase inhibitor L-NAME in the exercising horse
    Kindig, CA
    Gallatin, LL
    Erickson, HH
    Fedde, MR
    Poole, DC
    RESPIRATION PHYSIOLOGY, 2000, 120 (02): : 151 - 166
  • [50] Effect of nitric oxide on canine postprandial gastrointestinal motility
    Ojima, Y
    Okajima, M
    Toyota, K
    Arita, M
    Kobayashi, R
    Masaoka, Y
    Nakahara, M
    Kawahori, K
    Asahara, T
    Dohi, K
    GASTROENTEROLOGY, 1996, 110 (04) : A726 - A726